M/Z: 828.4843
Hit 3 annotations: Azaspiracid 3_[M+H]+
; Josamycin_[M+H]+
; PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))_[M+H]+
- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 15 Reference Ions Near m/z 828.4843
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000006154 Reliable | 828.4922 | 828.492 ~ 828.4927 MzDiff: 2.8 ppm |
Azaspiracid 3 (BioDeep_00000024364) Formula: C46H69NO12 (827.482) |
13.49 (100%) | Rattus norvegicus [UBERON:0004358] caput epididymis |
MSI_000063233 Reliable | 828.4922 | 828.492 ~ 828.4923 MzDiff: 1.0 ppm |
Azaspiracid 3 (BioDeep_00000024364) Formula: C46H69NO12 (827.482) |
0.44 (100%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000061213 Unreliable | 828.4935 | 828.4934 ~ 828.4939 MzDiff: 2.4 ppm |
Azaspiracid 3 (BioDeep_00000024364) Formula: C46H69NO12 (827.482) |
2.19 (100%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000021349 Unreliable | 828.4932 | 828.4932 ~ 828.4932 MzDiff: none |
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z)) (BioDeep_00000105223) Formula: C46H70NO10P (827.4737) |
1.05 (100%) | Mus musculus [UBERON:0001499] muscle of arm |
MSI_000002384 Unreliable | 828.4921 | 828.4921 ~ 828.4921 MzDiff: none |
Azaspiracid 3 (BioDeep_00000024364) Formula: C46H69NO12 (827.482) |
2.13 (100%) | Rattus norvegicus [UBERON:0001950] neocortex |
MSI_000003253 Unreliable | 828.4921 | 828.4921 ~ 828.4921 MzDiff: none |
Azaspiracid 3 (BioDeep_00000024364) Formula: C46H69NO12 (827.482) |
0.35 (100%) | Rattus norvegicus [UBERON:0002037] cerebellum |
MSI_000005288 Unavailable | 828.4921 | 828.4921 ~ 828.4921 MzDiff: none |
Azaspiracid 3 (BioDeep_00000024364) Formula: C46H69NO12 (827.482) |
-0.86 (100%) | Rattus norvegicus [UBERON:0002298] brainstem |
MSI_000005887 Unavailable | 828.4921 | 828.4921 ~ 828.4921 MzDiff: none |
Azaspiracid 3 (BioDeep_00000024364) Formula: C46H69NO12 (827.482) |
-0.86 (100%) | Rattus norvegicus [UBERON:0002435] striatum |
MSI_000026474 Unreliable | 828.486 | 828.486 ~ 828.486 MzDiff: none |
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z)) (BioDeep_00000105223) Formula: C46H70NO10P (827.4737) |
1.79 (100%) | Mus musculus [UBERON:0002048] lung |
MSI_000029175 Unreliable | 828.4777 | 828.4777 ~ 828.4777 MzDiff: none |
Not Annotated | 1.73 (0%) | Macropus giganteus [UBERON:0002336] corpus callosum |
MSI_000030319 Unreliable | 828.4873 | 828.4873 ~ 828.4873 MzDiff: none |
Not Annotated | 1.94 (0%) | Macropus giganteus [UBERON:0003027] cingulate cortex |
MSI_000058782 Unreliable | 828.4922 | 828.4922 ~ 828.4922 MzDiff: none |
Azaspiracid 3 (BioDeep_00000024364) Formula: C46H69NO12 (827.482) |
0.79 (100%) | Mus musculus [UBERON:0001950] neocortex |
MSI_000060156 Unavailable | 828.4919 | 828.4919 ~ 828.4919 MzDiff: none |
Azaspiracid 3 (BioDeep_00000024364) Formula: C46H69NO12 (827.482) |
-1.1 (100%) | Mus musculus [UBERON:0002298] brainstem |
MSI_000060351 Unreliable | 828.4919 | 828.4919 ~ 828.4919 MzDiff: none |
Azaspiracid 3 (BioDeep_00000024364) Formula: C46H69NO12 (827.482) |
0.23 (100%) | Mus musculus [UBERON:0002421] hippocampal formation |
MSI_000062264 Unavailable | 828.4939 | 828.4939 ~ 828.4939 MzDiff: none |
Azaspiracid 3 (BioDeep_00000024364) Formula: C46H69NO12 (827.482) |
-0.25 (100%) | Mus musculus [UBERON:0001950] neocortex |
Found 7 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
Azaspiracid 3 Formula: C46H69NO12 (827.482) Adducts: [M+H]+ (Ppm: 3.5) |
Rattus norvegicus (Brain) |
Spectroswiss - sol_2x_br_2Resolution: 17μm, 488x193
|
|
Josamycin Formula: C42H69NO15 (827.4667) Adducts: [M+H]+ (Ppm: 13.4) |
Mus musculus (Lung) |
image1Resolution: 40μm, 187x165
Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin.
Fig 1-3, Fig S1-S3, S5 |
|
Josamycin Formula: C42H69NO15 (827.4667) Adducts: [M+H]+ (Ppm: 16.1) |
Mus musculus (Lung) |
image3Resolution: 40μm, 146x190
Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z)) Formula: C46H70NO10P (827.4737) Adducts: [M+H]+ (Ppm: 6.1) |
Mus musculus (Lung) |
image4Resolution: 40μm, 162x156
Fig 6c
Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
Josamycin Formula: C42H69NO15 (827.4667) Adducts: [M+H]+ (Ppm: 12.5) |
Mus musculus (Lung) |
image5Resolution: 40μm, 163x183
Supplementary Figure S8. MALDI-MSI data of mouse lung tissue administered with D9-choline and
U 13C-DPPC–containing Poractant alfa surfactant (labels administered 18 h prior to sacrifice). Ion
images of (a) m/z 796.6856 ([U13C-DPPC+Na]+), (b) m/z 756.5154 [PC32:0+Na]+ and (c) m/z 765.6079
([D9-PC32:0+Na]+). (d) Overlay image of [U13C-DPPC+Na]+ (red) and [D9-PC32:0+Na]+ (green).
Parts per million (ppm) mass errors are indicated in parentheses. All images were visualised using totalion-current normalisation and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. |
|
m/z_828.4873 Formula: - (n/a) Adducts: (Ppm: 0) |
Macropus giganteus (Brain) |
170321_kangaroobrain-dan3-pos_maxof50.0_med1Resolution: 50μm, 81x50
Sample information
Organism: Macropus giganteus (kangaroo)
Organism part: Brain
Condition: Wildtype
Sample growth conditions: Wild |
|
Josamycin Formula: C42H69NO15 (827.4667) Adducts: [M+H]+ (Ppm: 15.7) |
Mus musculus (Liver) |
Salmonella_final_pos_recalResolution: 17μm, 691x430
A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium.
[dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671. |
|